Amedisys Inc

AMED's Fundamental analysis

Select the Comparisons :

None ▼

Select the Ratio:

None▼

None ▼

None▼

AMED Growth rates comparisons

Looking into Amedisys Inc growth rates, revenue grew by 0.49 % in IV. Quarter 2022 from the same quarter a year ago. Ranking at No. 1768

Healthcare Facilities industry recorded growth of revenues by 5.74 %

Amedisys Inc 's net profit deacreased by -7.24 % in IV. Quarter 2022 year on year, to $32 millions.

• More on AMED's Growth

AMED's Valuation comparisons

Amedisys Inc
current PE on trailing twelve month basis is above Healthcare Facilities industry average.

Company is currently trading with Price to Cash flow multiple of 277.37 in trailing twelve-month period. Healthcare Facilities industry recorded net loss in trailing twelve months.

Company

19.48

PE TTM

Industry

-0

PE TTM

Company's Price to Sales ratio is at 1.04.
Healthcare Facilities industry's Price to Sales ratio is at 0.52.

• More on AMED's Valuation

Total Debt (Millions $)	435
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Revenue/Employee (TTM) $	-
Net Income/Employee (TTM) $	-
Receivable Turnover (TTM)	7.42
Tangible Book Value (Per Share $)	-8.63

AMED's Valuation comparisons

Company

19.48

PE TTM

Industry

-0

PE TTM

Company's Price to Sales ratio is at 1.04.
Healthcare Facilities industry's Price to Sales ratio is at 0.52.

Amedisys Inc Price to Book Ratio is at 2.1 lower than Indusry Avg. of 45.56. and higher than S&P 500 Avg. of -0.01

• More on AMED's Valuation

• Market Capitalization (Millions $)	2,320
• Shares Outstanding (Millions)	33
• Employees	-
• Revenues (TTM) (Millions $)	2,223
• Net Income (TTM) (Millions $)	118
• Cash Flow (TTM) (Millions $)	8
• Capital Exp. (TTM) (Millions $)	-7
• Total Debt (Millions $)	435
• Dividend TTM ($)	0 $
• Dividend Yield TTM (%)	-
• Revenue/Employee (TTM) $	-
• Net Income/Employee(TTM) $	-
• Receivable Turnover Ratio (TTM)	7.42
• Tangible Book Value (Per Share $)	-8.63

• Market Capitalization (Millions $)	2,320
• Shares Outstanding (Millions)	33
• Employees	-
• Revenues (TTM) (Millions $)	2,223
• Net Income (TTM) (Millions $)	118
• Cash Flow (TTM) (Millions $)	8
• Capital Exp. (TTM) (Millions $)	-7

AMED's Profitability Comparisons
Amedisys Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2022 to 8.23 % from 6.98 % in III. Quarter. Amedisys Inc net profit margin of 5.61 % is currently ranking no. 11 in Healthcare Facilities industry, ranking no. 144 in Healthcare sector and number 1653 in S&P 500.

	*Ratio*
• Capital Ratio (MRQ)	1.21
• Total Debt to Equity (MRQ)	0.39
• Tangible Leverage Ratio (MRQ)	-
• Asset Turnover Ratio (TTM)	1.13
• Inventory Turnover Ratio (TTM)	-

AMED's Profitability Comparisons

Amedisys Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2022 to 8.23 % from 6.98 % in III. Quarter.

Amedisys Inc net profit margin of 5.61 % is currently ranking no. 11 in Healthcare Facilities industry, ranking no. 144 in Healthcare sector and number 1653 in S&P 500.

• More on AMED's Key Ratios


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar LDI's Profile Stock Price LDI's Financials Business Description Fundamentals Charts & Quotes LDI's News Suppliers LDI's Competitors Customers & Markets Economic Indicators LDI's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071